pubmed-article:19761780 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19761780 | lifeskim:mentions | umls-concept:C0009813 | lld:lifeskim |
pubmed-article:19761780 | lifeskim:mentions | umls-concept:C1760025 | lld:lifeskim |
pubmed-article:19761780 | lifeskim:mentions | umls-concept:C1261287 | lld:lifeskim |
pubmed-article:19761780 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
pubmed-article:19761780 | lifeskim:mentions | umls-concept:C0018036 | lld:lifeskim |
pubmed-article:19761780 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
pubmed-article:19761780 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
pubmed-article:19761780 | lifeskim:mentions | umls-concept:C0599946 | lld:lifeskim |
pubmed-article:19761780 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
pubmed-article:19761780 | lifeskim:mentions | umls-concept:C2684089 | lld:lifeskim |
pubmed-article:19761780 | lifeskim:mentions | umls-concept:C0205191 | lld:lifeskim |
pubmed-article:19761780 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:19761780 | pubmed:dateCreated | 2009-11-17 | lld:pubmed |
pubmed-article:19761780 | pubmed:abstractText | We explored the role of 20-hydroxy-5Z, 8Z, 11Z, 14Z-eicosatetraenoic acid (20-HETE) in oxygen-induced vasoconstriction in a normal renin form of hypertension [the 1 kidney-1 clip Goldblatt hypertensive rat (1K1C)] and a high renin form of hypertension [the 2 kidney-1 clip Goldblatt hypertensive rat (2K1C)]. A silver clip was placed around the left renal artery of adult Sprague-Dawley males. The right kidney was removed in the 1K1C group and left intact in the 2K1C group. Arteriolar responses to elevation of O(2) concentration in the superfusion solution from 0% O(2) to 21% O(2) were determined in the in situ cremaster muscle before and after inhibition of cytochrome P450 4A omega-hydroxylase (CYP450 4A) with N-methyl-sulfonyl-12, 12-dibromododec-11-enamide (DDMS). Arteriolar constriction to elevated PO(2) was enhanced in the chronic 1K1C but not the acute 1K1C or 2K1C. DDMS eliminated O(2)-induced arteriolar constriction in the 9-week 1K1C, but had no effect in the 2-week 1K1C, and only partially inhibited O(2)-induced constriction of arterioles in the 4-week 2K1C rat. These findings indicate that although the CYP4A/20-HETE system contributes to arteriolar constriction in response to elevated PO(2) in the established stage of 1K1C renovascular hypertension, physiological alterations in other mechanisms are the primary determinants of O(2)-induced constriction of arterioles in the early and developing stages of 1K1C and 2K1C hypertension. | lld:pubmed |
pubmed-article:19761780 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19761780 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19761780 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19761780 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19761780 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19761780 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19761780 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19761780 | pubmed:language | eng | lld:pubmed |
pubmed-article:19761780 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19761780 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19761780 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19761780 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19761780 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19761780 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19761780 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19761780 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19761780 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19761780 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19761780 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19761780 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19761780 | pubmed:month | Dec | lld:pubmed |
pubmed-article:19761780 | pubmed:issn | 1095-9319 | lld:pubmed |
pubmed-article:19761780 | pubmed:author | pubmed-author:FalckJohn RJR | lld:pubmed |
pubmed-article:19761780 | pubmed:author | pubmed-author:LombardJulian... | lld:pubmed |
pubmed-article:19761780 | pubmed:author | pubmed-author:KunertMary... | lld:pubmed |
pubmed-article:19761780 | pubmed:author | pubmed-author:FriesmaJillJ | lld:pubmed |
pubmed-article:19761780 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19761780 | pubmed:volume | 78 | lld:pubmed |
pubmed-article:19761780 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19761780 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19761780 | pubmed:pagination | 442-6 | lld:pubmed |
pubmed-article:19761780 | pubmed:dateRevised | 2011-3-3 | lld:pubmed |
pubmed-article:19761780 | pubmed:meshHeading | pubmed-meshheading:19761780... | lld:pubmed |
pubmed-article:19761780 | pubmed:meshHeading | pubmed-meshheading:19761780... | lld:pubmed |
pubmed-article:19761780 | pubmed:meshHeading | pubmed-meshheading:19761780... | lld:pubmed |
pubmed-article:19761780 | pubmed:meshHeading | pubmed-meshheading:19761780... | lld:pubmed |
pubmed-article:19761780 | pubmed:meshHeading | pubmed-meshheading:19761780... | lld:pubmed |
pubmed-article:19761780 | pubmed:meshHeading | pubmed-meshheading:19761780... | lld:pubmed |
pubmed-article:19761780 | pubmed:meshHeading | pubmed-meshheading:19761780... | lld:pubmed |
pubmed-article:19761780 | pubmed:meshHeading | pubmed-meshheading:19761780... | lld:pubmed |
pubmed-article:19761780 | pubmed:meshHeading | pubmed-meshheading:19761780... | lld:pubmed |
pubmed-article:19761780 | pubmed:meshHeading | pubmed-meshheading:19761780... | lld:pubmed |
pubmed-article:19761780 | pubmed:meshHeading | pubmed-meshheading:19761780... | lld:pubmed |
pubmed-article:19761780 | pubmed:meshHeading | pubmed-meshheading:19761780... | lld:pubmed |
pubmed-article:19761780 | pubmed:meshHeading | pubmed-meshheading:19761780... | lld:pubmed |
pubmed-article:19761780 | pubmed:meshHeading | pubmed-meshheading:19761780... | lld:pubmed |
pubmed-article:19761780 | pubmed:meshHeading | pubmed-meshheading:19761780... | lld:pubmed |
pubmed-article:19761780 | pubmed:meshHeading | pubmed-meshheading:19761780... | lld:pubmed |
pubmed-article:19761780 | pubmed:meshHeading | pubmed-meshheading:19761780... | lld:pubmed |
pubmed-article:19761780 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19761780 | pubmed:articleTitle | CYP450 4A inhibition attenuates O2 induced arteriolar constriction in chronic but not acute Goldblatt hypertension. | lld:pubmed |
pubmed-article:19761780 | pubmed:affiliation | Medical College of Wisconsin; Milwaukee, WI 53226, USA. mpkunert@uwm.edu | lld:pubmed |
pubmed-article:19761780 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19761780 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |